PCN113 - Cost Effectiveness of Cetuximab and Panitumumab for First-Line RAS WT Metastatic Colorecal Cancer
| Autor: | Tikhonova, I, Hoyle, M, Snowsill, T, Crathorne, L, Varley-Campbell, J, Peters, J, Briscoe, S, Bond, M, Huxley, N |
|---|---|
| Zdroj: | In Value in Health May 2016 19(3):A154-A154 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect